您的购物车当前为空
别名 FP-025, FP-003
Aderamastat (FP-025) 是一种具有口服活性的基质金属蛋白酶12(MMP-12)抑制剂,适用于过敏性哮喘、COPD与肺纤维化的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
Aderamastat (FP-025) 是一种具有口服活性的基质金属蛋白酶12(MMP-12)抑制剂,适用于过敏性哮喘、COPD与肺纤维化的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 995 | In Stock | |
| 5 mg | ¥ 2,480 | In Stock | |
| 10 mg | ¥ 3,970 | In Stock | |
| 25 mg | ¥ 6,380 | In Stock | |
| 50 mg | ¥ 8,590 | In Stock | |
| 100 mg | ¥ 11,600 | In Stock | |
| 200 mg | ¥ 15,600 | In Stock |
Aderamastat 相关产品
| 产品描述 | Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor indicated for the study of allergic asthma, COPD and pulmonary fibrosis. |
| 别名 | FP-025, FP-003 |
| 分子量 | 394.44 |
| 分子式 | C21H18N2O4S |
| CAS No. | 877176-23-3 |
| Smiles | O=C1NC(=O)C(N1)C=2OC=CC2SC3=CC=C(OCC=4C=CC=C(C4)C)C=C3 |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (202.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.37 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容